Cite
HARVARD Citation
Huober, J. et al. (2019). Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer. European journal of cancer. pp. 169-177. [Online].